Dhananjay Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 10.00 M
- Company Age 28 Year, 1 Month
- Last Filing with ROC 31 Mar 2012
- Open Charges ₹ 1.00 Cr
About Dhananjay Pharma
Dhananjay Pharma Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 December 1996 and has a history of 28 years and one month. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 10.00 M.
The company currently has active open charges totaling ₹1.00 Cr.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231PN1996PTC014958
-
Company No.
014958
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Dec 1996
-
Date of AGM
29 Sep 2012
-
Date of Balance Sheet
31 Mar 2012
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Dhananjay Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Belvalkar
|
Managing Director | 15-Apr-2003 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sharatchandra Belvalkar
|
Director | 15-Apr-2003 | Current |
|
Mohini Belvalkar
|
Director | 23-Aug-2003 | Current |
Financial Performance of Dhananjay Pharma.
Enhance accessibility to Dhananjay Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhananjay Pharma?
Unlock access to Dhananjay Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.00 Cr
₹0
Charges Breakdown by Lending Institutions
- The Shree Suvarna Sahakari Bank Ltd : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Aug 2004 | The Shree Suvarna Sahakari Bank Ltd | ₹1.00 Cr | Open |
How Many Employees Work at Dhananjay Pharma?
Unlock and access historical data on people associated with Dhananjay Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhananjay Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhananjay Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.